Main container

Casotti Chiara, MSc, PhD

CV

Qualification

Medical Biotechnologist

Current assignment

Scholarship

Title of qualification awarded

April 2025: PhD in Oncology, Hematology and Pathology

Other qualifications awarded
  • Master Degree in Medical Biotechnology at University of Modena and Reggio Emilia (Unimore) with vote 110/110
  • Bachelor Degree in Biotechnology at University of Bologna (Unibo)
  • Qualification to practice as a biologist
Positions held
  • From July 2025: Scholarship holder at the Osteoncology Department, Rizzoli Orthopedic Institute. Project: "Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy (DEEPLY)."
  • November 2024-June 2025: Scholarship holder at the Pharmacogenetics and Pharmacogenomics Department, affiliated with the Osteoncology Department. Project: "Toward Tailored Treatments for Osteosarcoma through Validation of Pharmacogenomic Markers."
  • November 2021-November 2024: PhD student at the Osteoncology Department, Rizzoli Orthopedic Institute. PhD in Oncology, Hematology, and Pathology, XXXVII cycle, at the University of Bologna. Project title: Analysis and validation of gene polymorphisms in osteosarcoma.
  • March 2024–September 2024: Research at the Institute for Technology Inspired Regenerative Medicine (MERLN), Maastricht, Netherlands, as a Marco Polo grant recipient. Duration of the study abroad: 6 months. Project title: Development of a 3D model of the kidney for the analysis of polymorphisms associated with toxicity.
Languages
  • English: fluent
  • Spanish: Good
Technologies
  • Molecular biology techniques: extraction of nucleic acids, expression analysis using Real Time PCR, NGS techniques for the analysis of gene polymorphisms, Immunohistochemistry.
  • Cell biology techniques: maintenance of human tumor cell lines, MTT, transfection by electroporation.
  • Good knowledge of Windows operating systems and Office package and software like Graph Pad e CLC genomics workbench
Clinical and/or Scientific interests

Study of polymorphisms of genes involved in the drug resistance of osteosarcoma